Found 8 matching trials
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Reverse Triple Negative Immune Resistant Breast Cancer PHASE2 This is a Phase II, open-label, seven-arm parallel study evaluating the eff...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer PHASE2 This is an open,multicentre phase Ib/II study. The purpose of phase Ib is t...
Show More Location
Zhongshan Hospital, FuDan University
Treatments Being Tested
SHR-A1811 and SHR-1701 SHR-A1811 and capecitabine SHR-A181, SHR-1701, and capecitabine SHR-A1811, SHR-1316, and capecitabine SHR-A1811, SHR-1316, capecitabine,and oxaliplatin SHR-A1811, SHR-1316, and 5-FU SHR-A1811, SHR-1316, and capecitabine SHR-1316 and SHR-A1811 SHR-A1811 and capecitabine SHR-A1811, SHR-1316, and 5-FU SHR-A1811and 5-FU SHR-A1811, SHR-1316, capecitabine,and oxaliplatin Learn More & Join Trial
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer PHASE1 This study was an open, multicenter, dose-increasing/investigational Phase ...
Show More Location
Shanghai Chest hospital
Learn More & Join Trial
Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer PHASE1 This study is designed to determine if treatments with the combination of H...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) PHASE2 This is a multicenter, open-label, Phase II clinical trial to evaluate the ...
Show More Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Learn More & Join Trial
A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer PHASE3 It is a randomized, open label, positive drug controlled, multicenter desig...
Show More Location
Cancer Hospital of Chinese Academy of Medical Sciences
Learn More & Join Trial
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer PHASE3 This study is to evaluate the progression-free survival (PFS) of SHR-A1811 ...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial